by Dr. Joseph Mercola, Mercola:
STORY AT-A-GLANCE
- In February 2021, Pfizer launched a randomized, placebo-controlled, observer-blind study to evaluate the safety of its COVID-19 shot — BNT162b2 — in healthy pregnant women
- The injections were set to take place between 24 and 34 weeks’ gestation, with participants randomized 1-to-1 to receive a COVID-19 shot or placebo
